Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

First-in-human phase I results for the tuberculosis vaccine MVA85A-IMX313

April 5, 2016

PTC Therapeutics presents antibacterial compounds

April 5, 2016

Astellas announces a new collaborative research agreement with AIST

April 4, 2016

BCHT initiates clinical trials of influenza vaccine in China

April 1, 2016

Genocea reports 12-month efficacy data from phase II trial of GEN-003 for genital herpes

April 1, 2016

FDA approves use of Roche Zika assay to screen blood donations under IND protocol

March 31, 2016

Gilead Sciences applies for approval of tenofovir alafenamide fumarate in Japan

March 31, 2016

FDA grants fast track designation for VL-2397 as treatment for invasive aspergillosis

March 31, 2016

Inovio announces promising results of human trial evaluating Ebola vaccine

March 31, 2016

Griffith University reports development of antiviral agents

March 30, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...